O f all neoplastic lesions and across all medical specialties, high-grade gliomas, including glioblastoma, are some of the most difficult tumors to treat. The combination of maximal resection followed by radiation therapy and adjuvant chemotherapy (temozolomide) is the standard treatment leading to the best clinical course. However, the prognosis remains unfavorable and most patients succumb to the disease.
been documented. In this report we present a patient with eosinophilic meningitis that developed after the implantation of Gliadel wafers. To the best of our knowledge, this is the first report of this rare complication.
Case Report

Patient History
This 61-year-old man with a history of alimentary allergy to beef presented with consciousness disturbance and left hemiparesis. MRI demonstrated an intraaxial mass in the right frontal lobe with marked perifocal edema and midline shift. The lesion had a heterogeneous component and manifested ring-like enhancement after the administration of contrast medium ( Fig. 1A and B) . Preoperatively, high-grade glioma, most likely glioblastoma, was strongly suspected and he underwent resection. Because intraoperative histopathological study demonstrated the proliferation of astrocytic cells with high cellularity, suggesting high-grade glioma, 8 carmustine wafers (Gliadel) were placed. Before their placement, the resection cavity was completely separated from the ventricular system using oxicellulose and fibrin glue. Postoperative histopathological examination revealed the lesion to be glioblastoma. His clinical condition improved and MRI confirmed the gross-total removal of the contrast-enhanced lesion ( Fig. 1C and D) . In accordance with the Stupp protocol we delivered adjuvant chemotherapy with temozolomide and concomitant radiotherapy.
Examination and Workup
On postoperative Day 21, 2 days after the start of adjuvant therapy, the patient experienced new symptoms including headache, vomiting, and progressive consciousness disturbance. No fever or neck rigidity was present and no other clinical signs of meningeal irritation were noted. A brain CT scan obtained on Day 7 showed no ventricular enlargement ( Fig. 2A) . A blood test performed on postoperative Day 25 revealed no evident cause of his consciousness disturbance except for a slight elevation of the eosinophil count. The white blood cell (WBC) count was 7500/μl (reference range 3300-8600/μl) with eosinophils accounting for 7.7% (reference range 0.7%-7.0%), and Creactive protein was 0.09 mg/dl (reference range < 0.14 mg/dl). His baseline kidney and liver function were normal. Considering the side effects of temozolomide, corticosteroids (dexamethasone 6.6 mg daily) were administered; they did not improve his symptoms.
CT studies showed progressive ventricular enlargement and expansion of the right frontal subdural space ( Fig. 2B  and C) . We considered the ventricular enlargement and symptoms to reflect secondary hydrocephalus. On postoperative Day 41 we performed emergency spinal drainage. CSF findings were suggestive of eosinophilic meningitis: the lumbar fluid was cloudy, protein was 224 mg/dl (reference range 10-40 mg/dl), the WBC count was 3990 cells/ mm 3 (reference range 0-5/mm 3 ), glucose was 20 mg/dl (50%-66% serum, serum glucose 93 mg/dl), and 95% of the cells were eosinophilic granulocytes (EGs).
The workup for eosinophilic meningitis by multiple-dot enzyme-linked immunosorbent assay ruled out parasitic infection. The serum b-D glucan level gave no evidence of fungal infection. The CSF culture was negative for bacteria and fungi. Cytologically there was no dissemination of the glioblastoma to the CSF. In blood tests immunoglobulin E (IgE) was 985.2 IU/ml (reference range 3.7-311.6 IU/ml); the eosinophil count continued to increase until insertion of the lumbar drain on Day 41 (Fig. 3) . We diagnosed his eosinophilic meningitis to be attributable to an allergic reaction. An allergy component-specific IgE test showed that the patient was allergic to latex, cedar pollen, Japanese cypress, and kiwi fruit. A drug lymphocyte stimulation test (DLST) was negative for Gliadel wafers and temozolomide but positive for polifeprosan (procured from Eisai Co. Ltd.), the biodegradable copolymer used to control the release of carmustine from Gliadel wafers. Although the insertion of a lumbar drain markedly reduced the EG count, his condition did not improve significantly.
Reoperation
On postoperative Day 55 we performed a right frontal craniotomy for debridement and the removal of all 8 Gliadel wafers and the surrounding brain parenchyma. A catheter was introduced into the left ventricular horn for ventricular drainage. During the reoperation, the tumor resection cavity was noted to communicate with the right anterior horn of the lateral ventricle via a small fissure in the oxycellulose. No wafer material had dislocated or migrated into the anterior horn.
Postoperative Course
Histological examination of the Gliadel wafers and brain tissue showed the accumulation of EGs around the wafers from the side of the resection cavity. In addition, eosinophilic infiltrates were observed in brain tissue around small vessels (Fig. 4) . After the removal of the Gliadel wafers the EG count in the CSF returned to the normal range (Fig. 3) . His hydrocephalus failed to improve. On Day 98 after the first surgery, a right occipital ventriculoperitoneal shunt was placed, which resolved the condition. After adjuvant therapy the patient was deemed stable and admitted to a related hospital for rehabilitation.
Discussion
Glioblastoma is the most aggressive and challenging cancer to treat. Despite the implementation of the current standard treatment (known as the "Stupp protocol"), the prognosis of patients with glioblastoma remains poor. Various additional molecular targeted therapies have been developed. Drugs available in Japan for the treatment of glioblastoma are limited to certain chemotherapeutic agents such as temozolomide and nimustine. Due to its efficacy, the use of Gliadel has increased in Japan. 1, 6 The implantation of Gliadel is not recommended when intraoperative opening of the ventricular system is expected, because the wafers may dislocate and migrate into the ventricular system, leading to obstructive hydrocephalus. However, Bock et al. 3 reported that sealing the ventricular system with fibrinogen-coated collagen fleece effectively separates the resection cavity and prevents Gliadel wafers from dislocating and contaminating the ventricular system. Taking that into consideration, we chose to use Gliadel wafers as adjuvant therapy in this case despite the opening of the ventricular system.
Due to the absence of meningeal irritation and general signs of inflammation, the diagnosis of eosinophilic meningitis was difficult in our patient. Follow-up CT studies showed only an expansion of the lateral ventricles and enlargement of the subdural space ipsilateral to the tumor resection cavity; these are considered to be nonspecific imaging findings. Study of the CSF obtained by lumbar drainage resulted in a diagnosis of eosinophilic meningitis. The presence of more than 10 eosinophils per microliter in the CSF or CSF eosinophilia of at least 10% is defined as eosinophilic meningitis, 15 a rare clinical condition. Its most common etiology is invasion of the CNS by parasites, especially Angiostrongylus cantonensis, Baylisascaris procyonis, and Gnathostoma spinigerum. 15 Other eliciting factors are fungal infection, syphilis, and tuberculosis. Noninfectious etiologies have also been reported. For example, some patients with lymphoma developed eosinophilic meningitis after ventriculoperitoneal shunting and after the intraventricular administration of antibiotics or iophendylate dye.
Different from eosinophilic meningitis attributable to infection, the noninfectious form does not tend to elicit the classic clinical signs of meningeal irritation such as nuchal rigidity. 8, 10, 16, 17 In our patient, besides the lack of signs of meningeal irritation, elevated allergy indicators led to a suspicion of an allergic reaction to the implanted Gliadel wafers. While our initial DLST results against Gliadel wafers per se failed to show a positive reaction, when we performed the test against the polifeprosan wafer matrix without BCNU the test was positive. We posit that our patient's allergic reaction to polifeprosan was veiled by the cell-killing effect of BCNU released by the wafers. Polifeprosan contains sebacic acid, 4 which has been reported to be capable of inducing an allergic reaction. It is an organic compound that is a derivative of castor oil obtained by pressing the seeds of the castor oil plant Ricinus communis. Cases of allergic contact dermatitis attributable to exposure to sebacic acid compounds have been reported. 13 Our patient manifested late-onset elevation of the blood eosinophil count; it was recognized 25 days after the implantation of the Gliadel wafers at the first operation. We believe that this reflects the lasting duration and the released concentration of BCNU from the Gliadel wafers. Fung et al. 9 reported that in the monkey brain, concentrations of carmustine (BCNU) were present in an area up to about 5 cm from the drug implant site for as long as 30 days. The time lag in the manifestation of elevated blood eosinophil levels may be attributable to the prolonged cytotoxicity of BCNU released by the Gliadel wafers and the accumulation of eosinophils might be inhibited early on. Taken together, our observations suggest that anticancer or immunosuppressant drugs may return false-negative DLST results due to cell destruction or the inhibition of immune-, and thus allergic reactions.
Our patient responded to the removal of all 8 Gliadel wafers and subsequent ventriculoperitoneal shunting. Suspecting adverse effects of temozolomide, as an initial treatment we administered corticosteroids to alleviate his symptoms. However, because this did not markedly improve his level of consciousness, headache, and vomiting, we next performed CSF drainage via a lumbar drain. Although the EG count in his CSF and blood was markedly reduced (Fig. 3) , it failed to return to the normal range. We posit that the EG count decreased before removal of the wafers on postoperative Day 55 because the antigen concentration in the CSF was markedly reduced after insertion of the lumbar drain on Day 41 (Fig. 3) . However, as the tumor resection cavity communicated with the lat- eral ventricle, the antigen was not removed completely. Based on his allergic diathesis and neurological status we decided to remove all Gliadel wafers and some of the surrounding brain tissue. Histological examination after the second operation revealed eosinophilic aggregates around the Gliadel wafers and the surrounding brain tissue, especially in the perivascular area. Although corticosteroids tend to improve eosinophilic meningitis, their administration had no significant beneficial effects. Only removal of the wafers and placement of a ventriculoperitoneal shunt resulted in his recovery.
To the best our knowledge, this is the first report of a patient with eosinophilic meningitis elicited by the implantation of Gliadel wafers. Because of its rarity, eosinophilic meningitis attributable to Gliadel wafers is difficult to predict, thus it is very important to be aware of their potential adverse effects. Before their placement, special attention must be paid in patients with an allergic diathesis. If there is a strong suspicion of eosinophilic meningitis after the placement of Gliadel wafers we recommend their immediate removal and CSF drainage.
